Literature DB >> 14964780

Effects of altered expression and localization of cyclophilin A on differentiation of p19 embryonic carcinoma cells.

Robert Chiu1, Osvaldo Rey, Jun-Qi Zheng, Jeffery L Twiss, Jun Song, Shen Pang, Kazunari K Yokoyama.   

Abstract

1. The retinoblastoma susceptibility gene product, p105Rb (RB), is an important regulator in the control of cell proliferation, differentiation, and apoptosis. Several cellular factors that complex with RB and exert their cellular regulatory functions have been identified, such as the RB:cyclophilin A (CypA) complex. 2. CypA is a cytoplasmic immunophilin and known for its involvement in T-cell differentiation and proliferation. Although CypA has a pivotal role in the immune response, its function in other signaling pathways is largely unknown. 3. In this study, we used a model of neuronal differentiation to demonstrate that the nuclear translocation of CypA, the appearance of hypophosphorylated RB and the enhancement of RB: CypA complex formation correlates with retinoic acid induced neuronal differentiation. 4. Inhibition of CypA expression results in repression of both the hypophosphorylated RB and the neuron-specific differentiation marker, class III beta tubulin. 5. The evidence of enriched CypA and colocalization of RB with CypA in the nucleus of primary adult sensory neurons substantiated the important event of RB-mediated neuronal differentiation of p19 EC cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14964780     DOI: 10.1023/b:cemn.0000005321.11544.cc

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  45 in total

1.  Translational control of ribosomal protein L4 mRNA is required for rapid neurite regeneration.

Authors:  J L Twiss; D S Smith; B Chang; E M Shooter
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

2.  Cyclosporin A regulates the levels of cyclophilin A in neuroblastoma cells in culture.

Authors:  A R Hovland; F G La Rosa; P G Hovland; W C Cole; A Kumar; J E Prasad; K N Prasad
Journal:  Neurochem Int       Date:  1999-09       Impact factor: 3.921

Review 3.  Nucleocytoplasmic transport: the soluble phase.

Authors:  I W Mattaj; L Englmeier
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  A unique cathepsin-like protease isolated from CV-1 cells is involved in rapid degradation of retinoblastoma susceptibility gene product, RB, and transcription factor SP1.

Authors:  T Nishinaka; Y H Fu; L I Chen; K Yokoyama; R Chiu
Journal:  Biochim Biophys Acta       Date:  1997-04-10

5.  Cyclophilin-A is involved in excitotoxin-induced caspase activation in rat neuronal B50 cells.

Authors:  Michela Capano; Sukaina Virji; Martin Crompton
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

6.  Retinoblastoma protein represses transcription by recruiting a histone deacetylase.

Authors:  L Magnaghi-Jaulin; R Groisman; I Naguibneva; P Robin; S Lorain; J P Le Villain; F Troalen; D Trouche; A Harel-Bellan
Journal:  Nature       Date:  1998-02-05       Impact factor: 49.962

7.  Rapid protein kinase D translocation in response to G protein-coupled receptor activation. Dependence on protein kinase C.

Authors:  O Rey; S H Young; D Cantrell; E Rozengurt
Journal:  J Biol Chem       Date:  2001-06-15       Impact factor: 5.157

8.  T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A.

Authors:  S Matsuda; T Moriguchi; S Koyasu; E Nishida
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

9.  Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpoint.

Authors:  J S Kim; F Pirnia; Y H Choi; P M Nguyen; B Knepper; M Tsokos; T W Schulte; M J Birrer; M V Blagosklonny; O Schaefer; J F Mushinski; J B Trepel
Journal:  Oncogene       Date:  2000-12-07       Impact factor: 9.867

10.  Dual roles of the retinoblastoma protein in cell cycle regulation and neuron differentiation.

Authors:  E Y Lee; N Hu; S S Yuan; L A Cox; A Bradley; W H Lee; K Herrup
Journal:  Genes Dev       Date:  1994-09-01       Impact factor: 11.361

View more
  7 in total

1.  Interaction of cyclophilin A with a novel binding protein, SR-25, and characterization of their expression pattern in Chinese hepatocellular carcinoma patients.

Authors:  Jian Chen; Ning Li; Peiwen Lian; Jiahui Wang; Peng Li; Zhaohua Gong; Lixin Jiang
Journal:  Oncol Lett       Date:  2016-11-07       Impact factor: 2.967

2.  Cyclophilin A is localized to the nucleus and controls meiosis in Saccharomyces cerevisiae.

Authors:  Miguel Arévalo-Rodríguez; Joseph Heitman
Journal:  Eukaryot Cell       Date:  2005-01

3.  Characterization of cyclophilin-encoding genes in Phytophthora.

Authors:  Pamela Hui Peng Gan; Weixing Shan; Leila M Blackman; Adrienne R Hardham
Journal:  Mol Genet Genomics       Date:  2009-02-17       Impact factor: 3.291

4.  Crystallization and preliminary X-ray crystallographic studies of human cyclophilin J.

Authors:  Hao Hu; Chao-Qun Huang; He-Li Liu; Yi Han; Long Yu; Ru-Chang Bi
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-01-20

Review 5.  The neuroprotective role of acupuncture and activation of the BDNF signaling pathway.

Authors:  Dong Lin; Ike De La Pena; Lili Lin; Shu-Feng Zhou; Cesar V Borlongan; Chuanhai Cao
Journal:  Int J Mol Sci       Date:  2014-02-21       Impact factor: 5.923

6.  Cyclophilin A (CypA) interacts with NF-κB subunit, p65/RelA, and contributes to NF-κB activation signaling.

Authors:  Shan Sun; Mian Guo; James Beiji Zhang; Albert Ha; Kazunari K Yokoyama; Robert H Chiu
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

7.  Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells.

Authors:  Olivier Preynat-Seauve; Casimir de Rham; Diderik Tirefort; Sylvie Ferrari-Lacraz; Karl-Heinz Krause; Jean Villard
Journal:  J Cell Mol Med       Date:  2009-03-13       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.